Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information

CIO (Greater China)



Dr. Fei Jiang is the Chief Investment Officer (Greater China) of CMS Group (0867.HK). He’s in charge of CMS’ strategic investment as well as business development in Greater China Region.

Dr. Jiang got his Ph.D. degree in chemical engineering from Syracuse University, New York at 2006, after receiving his bachelor degree, also in chemical engineering, from East China University of Science and Technology, Shanghai at 1998. 

After graduation, he joined Cell Genesys at South San Francisco, California, to develop cancer cell-based immunotherapy products, and AlphaVax Inc. at Research Triangle Park, North Carolina, to develop RSV and CMV vaccines. 

Dr. Jiang returned to China and joined in 3SBio (1530.HK) at 2010. He served as R&D Manager, and later R&D Director till 2013. He shifted his role to BD Director since 2013, and took care of business development and strategic alliance management for 3SBio. He joined in healthcare investment business since 2017, and served as the Executive Director of Guijing Capital and Sinopharm Capital, and the Managing Director of Aplus Capital successively.